The resistance of VHL-defective ccRCC to the HIF2α inhibitor may be at least partly mediated through the activity of VHL to recognize and regulate the stability or activity of non-HIFα substrate proteins. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.